Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes - PubMed (original) (raw)
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes
Peter Hovind et al. Diabetes Care. 2003 Apr.
Abstract
Objective: Conflicting evidence of a decline in incidence of microvascular complications in type 1 diabetes during the last decades has been reported. To assess recent trends in the cumulative incidence of diabetic microangiopathy in type 1 diabetes, we analyzed data from long-term prospective observational studies lasting >/=20 years.
Research design and methods: A total of 600 Caucasian patients with onset of type 1 diabetes between 1965 and 1984 were followed until death or until the year 2000. Patients were divided into four groups based on the year of diabetes onset: group A, 1965-1969 (n = 113); group B, 1970-1974 (n = 130); group C, 1975-1979 (n = 113); and group D, 1979-1984 (n = 244). Group A, B, and C are prevalence cohorts identified in 1984; group D is an inception cohort.
Results: In patients followed for >/=20 years, the cumulative incidence (95% CI) of diabetic nephropathy after 20 years of diabetes (urinary albumin excretion >300 mg/24 h) was reduced in patients with more recent diabetes onset (groups A-D): 31.1% (22.5-39.7) vs. 28.4% (19.8-37.0) vs. 18.9% (10.9-26.9) vs. 13.7% (6.2-21.2) (P = 0.015). Similarly, the cumulative incidence of proliferative retinopathy was as follows: 31.2% (22.2-39.8) vs. 30.3% (22.2-38.4) vs. 19.3% (11.2-27.4) vs. 12.5% (5.2-19.8) (P < 0.01). In the latter groups, antihypertensive treatment was started earlier, blood pressure and HbA(1c) were lower, and fewer patients smoked.
Conclusions: Our study demonstrates a decrease in the cumulative incidence of diabetic microangiopathy in type 1 diabetes over the past 35 years. Improved glycemic control, lower blood pressure (in part due to early aggressive antihypertensive treatment), and reduced prevalence of smoking rates were associated with the improved prognosis.
Similar articles
- Incidence and development of diabetic microangiopathy of fulminant type 1 diabetes--comparison with non-fulminant type 1 diabetes.
Takaike H, Uchigata Y, Nakagami T, Iwamoto Y. Takaike H, et al. Intern Med. 2010;49(12):1079-83. doi: 10.2169/internalmedicine.49.3294. Epub 2010 Jun 15. Intern Med. 2010. PMID: 20558921 - Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
Nordwall M, Arnqvist HJ, Bojestig M, Ludvigsson J. Nordwall M, et al. Pediatr Diabetes. 2009 May;10(3):168-76. doi: 10.1111/j.1399-5448.2008.00472.x. Epub 2008 Oct 22. Pediatr Diabetes. 2009. PMID: 19175900 - Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy--a nationwide 5-year-study in Japan.
Murase Y, Imagawa A, Hanafusa T, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H. Murase Y, et al. Diabetologia. 2007 Mar;50(3):531-7. doi: 10.1007/s00125-006-0575-y. Epub 2007 Jan 18. Diabetologia. 2007. PMID: 17235525 - The changing epidemiology of diabetic microangiopathy in type 1 diabetes.
Rossing P. Rossing P. Diabetologia. 2005 Aug;48(8):1439-44. doi: 10.1007/s00125-005-1836-x. Epub 2005 Jun 29. Diabetologia. 2005. PMID: 15986235 Review. - Epidemiology of microangiopathy in type 1 diabetes mellitus. A review.
Borch-Johnsen K. Borch-Johnsen K. Diabete Metab. 1993;19(1 Pt 2):133-7. Diabete Metab. 1993. PMID: 8314416 Review.
Cited by
- Prevalence of diabetic retinopathy in the United States, 2005-2008.
Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW, Albright AL, Klein BE, Klein R. Zhang X, et al. JAMA. 2010 Aug 11;304(6):649-56. doi: 10.1001/jama.2010.1111. JAMA. 2010. PMID: 20699456 Free PMC article. - Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis.
Wong TY, Mwamburi M, Klein R, Larsen M, Flynn H, Hernandez-Medina M, Ranganathan G, Wirostko B, Pleil A, Mitchell P. Wong TY, et al. Diabetes Care. 2009 Dec;32(12):2307-13. doi: 10.2337/dc09-0615. Diabetes Care. 2009. PMID: 19940227 Free PMC article. - Cardiovascular risk in type 1 diabetes mellitus.
Slim IB. Slim IB. Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S7-S13. doi: 10.4103/2230-8210.119489. Indian J Endocrinol Metab. 2013. PMID: 24251225 Free PMC article. Review. - Lipid biology of the podocyte--new perspectives offer new opportunities.
Fornoni A, Merscher S, Kopp JB. Fornoni A, et al. Nat Rev Nephrol. 2014 Jul;10(7):379-88. doi: 10.1038/nrneph.2014.87. Epub 2014 May 27. Nat Rev Nephrol. 2014. PMID: 24861084 Free PMC article. Review. - The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal anti-VEGF treatment.
Tremolada G, Del Turco C, Lattanzio R, Maestroni S, Maestroni A, Bandello F, Zerbini G. Tremolada G, et al. Exp Diabetes Res. 2012;2012:728325. doi: 10.1155/2012/728325. Epub 2012 Apr 11. Exp Diabetes Res. 2012. PMID: 22566995 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous